Silencing of COX-2 by RNAi Modulates Epithelial-Mesenchymal Transition in Breast Cancer Cells Partially Dependent on the PGE2 Cascade |
Cao, Juan
(Department of Health Care, Weifang Medical University)
Yang, Xiao (Nursing School, Weifang Medical University) Li, Wen-Tong (Department of Pathology, Weifang Medical University) Zhao, Chun-Ling (Department of Biology, Weifang Medical University) Lv, Shi-Jun (Department of Pathology, Weifang Medical University) |
1 | Ansieau S (2013). EMT in breast cancer stem cell generation. Cancer Lett, 338, 63-8. DOI |
2 | Arboleda MJ, Lyons JF, Kabbinavar FF, et al (2003). Overexpression of AKT2/protein kinase Bbeta leads to up-regulation of beta1 integrins, increased invasion, and metastasis of human breast and ovarian cancer cells. Cancer Res, 63, 196-206. |
3 | Bellacosa A, Testa JR, Moore R, Larue, L (2004). A portrait of AKT kinases: human cancer and animal models depict a family with strong individualities. Cancer Biol Ther, 3, 268-75. DOI |
4 | Bocca C, Bozzo F, Bassignana A, Miglietta A (2011). Antiproliferative effects of COX-2 inhibitor celecoxib on human breast cancer cell lines. Mol Cell Biochem, 350, 59-70. DOI |
5 | Cheng J, Fan XM (2013). Role of cyclooxygenase-2 in gastric cancer development and progression. World J Gastroenterol, 19, 7361-8. DOI |
6 | Dohadwala M, Yang SC, Luo J, et al (2006). Cyclooxygenase- 2-dependent regulation of E-cadherin: prostaglandin E(2) induces transcriptional repressors ZEB1 and snail in nonsmall cell lung cancer. Cancer Res, 66, 5338-45. DOI ScienceOn |
7 | Falandry C, Canney PA, Freyer G, Dirix LY (2009). Role of combination therapy with aromatase and cyclooxygenase-2 inhibitors in patients with metastatic breast cancer. Ann Oncol, 20, 615-20. DOI ScienceOn |
8 | Gonzalez-Villasana V, Gutierrez-Puente Y, Tari AM (2013). Cyclooxygenase-2 utilizes Jun N-terminal kinases to induce invasion, but not tamoxifen resistance, in MCF-7 breast cancer cells. Oncol Rep, 30, 1506-10. |
9 | Harris RE (2007). Cyclooxygenase-2 (cox-2) and the inflammogenesis of cancer. Subcell Biochem, 42, 93-126. DOI |
10 | Harris RE (2009). Cyclooxygenase-2 (cox-2) blockade in the chemoprevention of cancers of the colon, breast, prostate, and lung. Inflammopharmacology, 17, 55-67. DOI ScienceOn |
11 | Hennessy BT, Smith DL, Ram PT, Lu Y, Mills GB (2005). Exploiting the PI3K/AKT pathway for cancer drug discovery. Nat Rev Drug Discov, 4, 988-1004. DOI ScienceOn |
12 | Hoellen F, Kelling K, Dittmer C, et al (2011). Impact of cyclooxygenase-2 in breast cancer. Anticancer Res, 31, 4359-67. |
13 | Huber MA, Kraut N, Beug H (2005). Molecular requirements for epithelial-mesenchymal transition during tumor progression. Curr Opin Cell Biol, 17, 548-58. DOI |
14 | Jendrossek V (2013). Targeting apoptosis pathways by Celecoxib in cancer. Cancer Lett, 332, 313-24. DOI |
15 | Kalluri R, Weinberg RA (2009). The basics of epithelialmesenchymal transition. J Clin Invest, 119, 1420-8. DOI ScienceOn |
16 | Ksiazkiewicz M, Markiewicz A, Zaczek AJ (2012). Epithelialmesenchymal transition: a hallmark in metastasis formation linking circulating tumor cells and cancer stem cells. Pathobiology, 79, 195-208. DOI |
17 | Kudo-Saito C, Shirako H, Takeuchi T, Kawakami Y (2009). Cancer metastasis is accelerated through immunosuppression during Snail-induced EMT of cancer cells. Cancer cell, 15, 195-206. DOI |
18 | Li Q, Mattingly RR (2008). Restoration of E-cadherin cellcell junctions requires both expression of E-cadherin and suppression of ERK MAP kinase activation in Rastransformed breast epithelial cells. Neoplasia, 10, 1444-58. DOI |
19 | Kulkarni S, Patil DB, Diaz LK, et al (2008). COX-2 and PPARgamma expression are potential markers of recurrence risk in mammary duct carcinoma in-situ. BMC Cancer, 8, 36. DOI |
20 | Lester RD, Jo M, Montel V, Takimoto S, Gonias SL (2007). uPAR induces epithelial-mesenchymal transition in hypoxic breast cancer cells. J Cell Biol, 178, 425-36. DOI ScienceOn |
21 | Li W, Liu C, Tang Y, Li H, Zhou F, Lv S (2011). Overexpression of Snail accelerates adriamycin induction of multidrug resistance in breast cancer cells. Asian Pac J Cancer Prev, 12, 2575-80. |
22 | Moody SE, Perez D, Pan TC, et al (2005). The transcriptional repressor Snail promotes mammary tumor recurrence. Cancer Cell, 8, 197-209. DOI ScienceOn |
23 | Nam EH, Lee Y, Park YK, Lee JW, Kim S (2012). ZEB2 upregulates integrin alpha5 expression through cooperation with Sp1 to induce invasion during epithelial-mesenchymal transition of human cancer cells. Carcinogenesis, 33, 563-71. DOI ScienceOn |
24 | Ogunwobi OO, Wang T, Zhang L, Liu C (2012). Cyclooxygenase-2 and Akt mediate multiple growth-factor-induced epithelialmesenchymal transition in human hepatocellular carcinoma. J Gastroenterol Hepatol, 27, 566-78. DOI |
25 | Park JW, Park JE, Lee JA, Lee CW, Kim CM (2006). Cyclooxygenase-2 (COX-2) is directly involved but not decisive in proliferation of human hepatocellular carcinoma cells. J Cancer Res Clin Oncol, 132, 184-92. DOI |
26 | Thiel A, Mrena J, Ristimaki A (2011). Cyclooxygenase-2 and gastric cancer. Cancer Metastasis Rev, 30, 387-95. DOI |
27 | Patel AR, Chougule MB, Patlolla R, Wang G, Singh M (2013). Efficacy of aerosolized celecoxib encapsulated nanostructured lipid carrier in non-small cell lung cancer in combination with docetaxel. Pharm Res, 30, 1435-46. DOI |
28 | Roxanis I (2013). Occurrence and significance of epithelialmesenchymal transition in breast cancer. J Clin Pathol, 66, 517-21. DOI ScienceOn |
29 | Sooriakumaran P, Coley HM, Fox SB, et al (2009). A randomized controlled trial investigating the effects of celecoxib in patients with localized prostate cancer. Anticancer Res, 29, 1483-8. |
30 | Thompson EW, Newgreen DF, Tarin D (2005). Carcinoma invasion and metastasis: a role for epithelial-mesenchymal transition? Cancer Res, 65, 5991-5; discussion 5995. |
31 | Vandesompele J, De Preter K, Pattyn F, et al (2002). Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol, 3, 34. |
32 | Wang WS, Yu SL, Yang XS, Chang SD, Hou JQ (2013). Expression and significance of twist and E-cadherin in ovarian cancer tissues. Asian Pac J Cancer Prev, 14, 669-72. 과학기술학회마을 DOI ScienceOn |
33 | Williams CS, Mann M, DuBois RN (1999). The role of cyclooxygenases in inflammation, cancer, and development. Oncogene, 18, 7908-16. |
34 | Xin X, Majumder M, Girish GV, et al (2012). Targeting COX-2 and EP4 to control tumor growth, angiogenesis, lymphangiogenesis and metastasis to the lungs and lymph nodes in a breast cancer model. Lab Invest, 92, 1115-28. DOI |
35 | Zhu QC, Gao RY, Wu W, Qin HL (2013). Epithelial-mesenchymal transition and its role in the pathogenesis of colorectal cancer. Asian PacJ Cancer Prev, 14, 2689-98. DOI ScienceOn |